DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in GILD — Gilead Sciences, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$332,035,416
+$36,155,835 QoQ
Shares Held
2,628,110
+23.8% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#62
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2020CallValue
$6,728,400
CallShares
90,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $6,628,918,596 across 11 Drug Manufacturers - General names. GILD ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,720,479 | $2,222,437,225 | |
| 2 | LLY |
ELI LILLY & Co
|
1,338,915 | $1,605,934,947 | |
| 3 | JNJ |
Johnson & Johnson
|
5,378,305 | $1,365,928,118 | |
| 4 | ABBV |
AbbVie Inc.
|
2,885,557 | $726,121,560 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
2,628,110 | $332,035,416 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,506,793 | $193,622,900 | |
| 7 | AMGN |
Amgen Inc
|
278,356 | $100,798,272 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
895,583 | $51,603,492 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,035,416 | 2,628,110 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $295,879,581 | 2,122,979 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $250,736,338 | 2,042,825 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $206,911,992 | 1,864,072 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $60,037,432 | 541,512 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $59,749,539 | 533,240 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $27,717,832 | 300,074 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $31,336,037 | 373,760 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $27,116,523 | 395,227 | Shares | Sole | 2026-05-04 | |
| 2024-03-31 | $21,448,918 | 292,818 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $27,380,810 | 337,993 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $25,963,861 | 346,462 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $63,672,689 | 826,167 | Shares | Sole | 2026-05-04 | |
| 2023-03-31 | $100,057,421 | 1,205,947 | Shares | Sole | 2026-05-04 | |
| 2022-12-31 | $55,941,318 | 651,617 | Shares | Defined | 2026-05-04 | |
| 2022-09-30 | $33,147,331 | 537,321 | Shares | Defined | 2026-05-04 | |
| 2022-06-30 | $35,571,716 | 575,501 | Shares | Defined | 2026-05-04 | |
| 2022-03-31 | $38,985,406 | 655,768 | Shares | Defined | 2026-05-04 | |
| 2021-12-31 | $33,817,017 | 465,735 | Shares | Defined | 2026-05-04 | |
| 2021-09-30 | $58,946,203 | 843,897 | Shares | Defined | 2026-05-04 | |
| 2021-06-30 | $48,085,762 | 698,312 | Shares | Defined | 2026-05-04 | |
| 2021-03-31 | $15,780,639 | 244,169 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $30,532,200 | 524,068 | Shares | Defined | 2026-05-04 | |
| 2020-09-30 | $86,698,507 | 1,372,029 | Shares | Defined | 2026-05-04 | |
| 2020-06-30 | $107,950,587 | 1,403,049 | Shares | Defined | 2026-05-04 | |
| 2020-03-31 | $142,912,333 | 1,911,615 | Shares | Defined | 2026-05-04 | |
| 2020-03-31 | $6,728,400 | 90,000 | Call | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||